Curative Biosciences, Inc. is engaged in the development and marketing of novel therapeutics. The company is headquartered in Miami, Florida. The company went IPO on 2004-08-26. The Company’s product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The firm through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.
Follow-Up Questions
Curative Biosciences Inc의 CEO는 누구입니까?
Richard Damion은 2013부터 회사에 합류한 Curative Biosciences Inc의 Chief Executive Officer입니다.
CBDX 주식의 가격 성능은 어떻습니까?
CBDX의 현재 가격은 $0.0001이며, 전 거래일에 decreased 0% 하였습니다.
Curative Biosciences Inc의 주요 사업 주제나 업종은 무엇입니까?
Curative Biosciences Inc은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
